Netherlands· NL-6ab27a76ec5a
Vaxchora, bruispoeder en poeder voor orale suspensie
A cholera, lebend, abgeschwächt product containing levend verzwakt v.cholera serotype o1 inaba, stam cvd 103-hgr, registered in Netherlands by Bavarian Nordic A/S. The same ATC class is registered in 10 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Cholera, lebend, abgeschwächt is registered in 10 of 19 countries.
Countries holding a registration under ATC J07AE02 (cholera, lebend, abgeschwächt), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 6 of them publish a price we can compare per daily dose
Cholera, lebend, abgeschwächt · ATC J07AE02
10 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- LEVEND VERZWAKT V.CHOLERA SEROTYPE O1 INABA, STAM CVD 103-HGR
- Manufacturer
- Bavarian Nordic A/S
- Country
- Netherlands (NL)
- ATC code
- J07AE02
- ATC class
- Cholera, lebend, abgeschwächt
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/20/1423
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AE02
Cholera, lebend, abgeschwächt, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/595ff1e2-6e1d-4477-9146-ddb14fb42650 GET /v1/drugs/595ff1e2-6e1d-4477-9146-ddb14fb42650?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Poeder voor orale suspensie",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/vaxchora-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Cholera, Live Attenuated",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp124455",
"excipients": [
"ASCORBINEZUUR (E 300)",
"ASCORBINEZUUR (E 300)",
"CASEÏNE HYDROLYSAAT",
"LACTOSE 0-WATER",
"LACTOSE 0-WATER",
"NATRIUMCARBONAAT 0-WATER (E 500 (I))",
"NATRIUMWATERSTOFCARBONAAT (E 500 (II))",
"SACCHAROSE"
],
"substances": [
"LEVEND VERZWAKT V.CHOLERA SEROTYPE O1 INABA, STAM CVD 103-HGR"
],
"leaflet_url": null,
"authorised_at": "2020/04/01",
"procedure_number": "EMEA/H/C/003876",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/20/1423",
"additional_monitoring": "N"
}See everything about cholera, lebend, abgeschwächt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.